April 24, 2018 by Chain Drug Review
2018 NACDS Annual Meeting, Panzer
Featured Articles, Leading Headlines, Pharmacy, Retail News, Supplier News, Uncategorized
PALM BEACH, Fla. — In his first remarks as chairman of the National Association of Chain Drug Stores, Mark Panzer thanked those who have taught and collaborated with him throughout his 46-year retail career. He said that NACDS chain and associate members alike can rely on the same formula of “listen, learn and engage” to
April 24, 2018 by Chain Drug Review
Mark Panzer, NACDS
Featured Articles, Issue 04-23-2018, Leading Headlines, News, Pharmacy, Retail News
BOISE, Idaho — Mark Panzer, chairman of the National Association of Chain Drug Stores, has been involved with the chain drug business for over 40 years. During that time, he has seen the industry transformed, above all by consolidation, but also in response to broader changes in retailing and consumer behavior as well as changing
April 23, 2018 by Chain Drug Review
chain drug stores
Featured Articles, Issue 04-23-2018, Leading Headlines, News
NEW YORK — This isn’t your father’s chain drug industry. It’s not even your older brother’s. The mergers of CVS Health and Aetna Inc. and Rite Aid Corp. and Albertsons Cos. are recasting two of the top three players and, in the process, redefining what it means to be a drug store operator. “Prescriptions, O-T-Cs
April 22, 2018 by Chain Drug Review
NACDS, Steve Anderson
Featured Articles, Issue 04-23-2018, Leading Headlines, News, Pharmacy, Retail News
ARLINGTON, Va. — In the currently chaotic public policy environment, the ability of the National Association of Chain Drug Stores to remain both focused and nimble in support of its industry has been a huge asset to the NACDS membership. As NACDS president and chief executive officer Steve Anderson pointed out earlier this year, the
April 21, 2018 by Chain Drug Review
Balance Rewards loyalty program, Fla., Gainsville, Walgreens, Walgreens Plus, Walgreens.com
Featured Articles, Leading Headlines, Retail News, Slideshows
GAINESVILLE, Fla. — Walgreens is launching a pilot program here that incorporates new approaches to pricing, promotions, product assortment and service offerings to create a new customer experience. The program, which has been implemented in 17 stores in the Gainesville area, will be monitored over the next 12 to 18 months to gauge customer reaction
April 18, 2018 by Chain Drug Review
earnings, Fred's, Mike Bloom, specialty pharmacy
Featured Articles, Leading Headlines, Pharmacy, Retail News
MEMPHIS — Fred’s Inc. has announced plans to sell its specialty pharmacy business. The disclosure led the company to delay publication of its fourth quarter and 2017 full-year results. An earnings call that was slated for today is now expected to be held May 4. A filing yesterday with the Securities and Exchange Commission says
April 16, 2018 by Chain Drug Review
CVS, CVS Health, CVS Pharmacy, Kevin Hourican
Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — Kevin Hourican has been promoted to president of CVS Pharmacy, the retail division of CVS Health. Hourican, who most recently served as the company’s executive vice president of retail pharmacy, had been serving as interim president of the drug chain following the departure of Helena Foulkes, who left to head Hudson’s Bay Co. In his
April 12, 2018 by Bill Schiffner
Albertsons-Rite Aid merger, John Standley, Kermit Crawford, Rite Aid
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. on Thursday reported net income of $767.1 million, or 73 cents per diluted share, for the fourth quarter ended March 3. The company showed a net loss from continuing operations of $483.7 million, or 46 cents per diluted share, for the quarter. Adjusted net loss from continuing operations
April 11, 2018 by Chain Drug Review
CVS Health, CVS Pharmacy, CVS Pharmacy Rx Savings Finder, Dr. Troy Brennan, executive vice president and chief medical officer at CVS Health, executive vice president of retail pharmacy, ising prescription drug prices, Kevin Hourican, Thomas Moriarty
Featured Articles, Leading Headlines, Pharmacy
WOONSOCKET, R.I. — CVS Health has revealed a new, comprehensive program designed to combat rising prescription drug prices and help patients save money on their medications. The new initiatives are being launched against a background of ongoing increases in manufacturers’ list prices for drugs and a growing percentage of Americans who have high-deductible health plans.
April 5, 2018 by Chain Drug Review
Ahold Delhaize, Dick Boer, Mats Jansson, rans Muller
Business, Featured Articles
ZAANDAM, Netherlands — Ahold Delhaize announced on Thursday that Dick Boer will be stepping down as chief executive officer as of July 1 and will retire from the company. Frans Muller has been appointed as the new CEO, effective July 1. “We thank Dick for his leadership and dedication throughout his 20-year career at Ahold Delhaize
April 4, 2018 by Chain Drug Review
Alan Lotvin, chronic kidney disease and dialysis, CVS Health
Featured Articles, Leading Headlines, Pharmacy
WOONSOCKET, R.I.— CVS Health announced an exciting new initiative that will focus on chronic kidney disease and dialysis and builds upon the company’s focus on driving innovation in the management of chronic disease to help improve patient health outcomes while managing costs. This new program will focus on early identification of kidney disease and expansion of
March 30, 2018 by Bill Schiffner
Healthcare, Humana, Walmart
Featured Articles, Leading Headlines, Retail News
NEW YORK — According to a report in The Wall Street Journal on Friday, Walmart and health insurer Humana are in early talks regarding a possible merger. WSJ says it isn’t clear what terms the companies may be discussing, and the story said there is no guarantee they will strike a deal. However, if they
March 29, 2018 by Chain Drug Review
McKesson Corp.
Featured Articles, Leading Headlines, News
SAN FRANCISCO — As the severity of the American opioid epidemic continues to deepen, government agencies — along with the White House — and private sector companies are joining the fight to stop it. On Thursday, McKesson Corp. announced a series of company initiatives aimed at combatting the crisis. The measures include the formation
March 28, 2018 by Bill Schiffner
AllianceRx Walgreens Prime, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) reported better-than-expected earnings and revenue on Wednesday when it announced results for the second quarter of fiscal 2018, which ended February 28. Overall, WBA earned $1.73 a share, up 27% versus a year ago. Revenue grew 12.1% to $33.02 billion. Same-store sales rose 2.4%, with comparable-pharmacy sales up